BPC-157
BPC-157 is a synthetically derived, 15-amino acid partial sequence of a natural body protection compound discovered in human gastric juice. Clinically revered in regenerative medicine, this pentadecapeptide exhibits profound systemic healing properties by radically accelerating the repair of muscle, tendon, ligament, and mucosal tissue. Often referred to as the "Wolverine Peptide," it is heavily utilized in sports optimization and physical therapy for both catastrophic injuries and chronic tendinopathies.
Quick Stats
Scientific Data
Patient Suitability
✓ Best For
- Tendon and ligament injuriesSprains, strains, tears, tendinitis - accelerates collagen synthesis
- Gut healingIBS, leaky gut, ulcers, inflammatory bowel conditions
- Muscle injuriesStrains, post-workout recovery, chronic muscle issues
- Joint problemsArthritis support, joint pain, cartilage issues
✗ Avoid If
- Pregnancy
- Breastfeeding
- Active cancer
- History of cancer
! Use With Caution If
- Chronic medical conditions
- Prescription medication use
- History of allergic reactions
Mechanism of Action
BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids derived from human gastric juice. Its primary mechanism involves upregulation of growth factor expression, including VEGF (Vascular Endothelial Growth Factor) and FGF (Fibroblast Growth Factor), which promote angiogenesis — the formation of new blood vessels. This enhanced blood supply accelerates tissue repair in tendons, ligaments, muscles, and the gastrointestinal tract.
BPC-157 also modulates the nitric oxide (NO) system, which plays a critical role in blood vessel formation and wound healing. Studies demonstrate its ability to counteract the damage caused by NSAIDs on the gastric mucosa, and to promote tendon-to-bone healing in animal models. It has additionally shown neuroprotective effects and the ability to counteract dopaminergic system disturbances.
Source: PMID: 29936067, PMID: 30915550
Background & History
BPC-157 (Body Protection Compound-157) was first isolated from human gastric juice by Croatian pharmacologist Predrag Sikiric in the 1990s. The 15-amino-acid pentadecapeptide was engineered to be stable in gastric acid — unlike most peptides — enabling both oral and injectable administration. Decades of animal model research at the University of Zagreb have documented its systemic healing effects across virtually every tissue type.
Research Use Cases
- ✓Tendon and ligament repair after acute injury or overuse
- ✓Gastrointestinal healing: IBD, leaky gut, NSAID-induced ulcers
- ✓Accelerating bone fracture healing
- ✓Nerve repair and neuroprotection after spinal or peripheral injury
- ✓Reducing post-surgical adhesions and inflammation
Dosing Protocols
Starting Dose
Standard Protocol
Advanced Protocol
When to Increase:
- Current dose is well-tolerated for 2+ weeks
- Desired effects not yet noticeable
- Healthcare provider recommends dose increase
When to Decrease:
- Side effects become bothersome or persistent
- Desired effects achieved at lower dose
- Healthcare provider recommends reduction
Body-Weight Dosing Reference
Estimated doses extrapolated from the published research range of 200–800 mcg/day (referenced to 70 kg / 154 lb). These are approximations — consult a qualified healthcare provider for personalised guidance.
| Weight | Low Dose | Target Dose | High Dose |
|---|---|---|---|
| 120 lb(54 kg) | 154 mcg | 386 mcg | 617 mcg |
| 140 lb(63 kg) | 180 mcg | 450 mcg | 720 mcg |
| 160 lb(73 kg) | 209 mcg | 521 mcg | 834 mcg |
| 180 lb(82 kg) | 234 mcg | 586 mcg | 937 mcg |
| 200 lb(91 kg) | 260 mcg | 650 mcg | 1040 mcg |
| 220 lb(100 kg) | 286 mcg | 714 mcg | 1143 mcg |
| 250 lb(113 kg) | 323 mcg | 807 mcg | 1291 mcg |
💉 For exact syringe units based on your vial concentration, use the BPC-157 Reconstitution Calculator →
Administration & Storage
Preparation
- Bacteriostatic water (BAC water)
- Insulin syringes (29-31 gauge)
- Alcohol swabs
- Sharps container
Storage Guidelines
Reconstitution Example
Safety & Considerations
BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses. Maintain sterile injection technique and consult a healthcare provider.
Regulatory & Legal Status
FDA Category 2 (higher-risk compound) — not approved for human use
Competitive athletes subject to anti-doping controls should not use BPC-157.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Interactions & Contraindications
Avoid concurrent use with active cancer treatment — angiogenic properties may theoretically promote tumor vascularization. NSAIDs blunt the prostaglandin pathway BPC-157 modulates; minimize concurrent use. No established drug-drug interactions with common medications at research doses.
Synergies & Common Stacks
The most studied peptide stack for recovery: BPC-157 drives localized VEGF/FGF healing while TB-500 provides systemic actin-mediated repair. Together they cover both local and systemic dimensions.
GHK-Cu amplifies collagen synthesis alongside BPC-157's angiogenic effects, enhancing tissue remodeling especially in skin and connective tissue repairs.
MGF activates satellite cells for muscle repair while BPC-157 handles the vascular and structural repair phase, making this stack useful for muscle injuries.
BPC-157 vs. TB-500
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice pentadecapeptide (human) | Thymosin β4 (Tβ4) synthetic fragment |
| Mechanism | VEGF/FGF angiogenesis + NO pathway | Actin polymerization + cell migration |
| Best For | Localized tissue healing + gut repair | Systemic whole-body healing |
| Injection Site | Near injury site preferred | Any site — systemic distribution |
| Dose Frequency | 250–500 mcg 1–2× daily | 2–5 mg 2× weekly (loading phase) |
| WADA Status | Prohibited (S0) | Prohibited (S0) |
| Evidence Level | Preclinical (animal models) | Preclinical (limited human data) |
Verdict: BPC-157 is best for localized injury healing and GI repair; TB-500 distributes systemically and addresses whole-body repair via the actin signaling axis. Most research protocols combine both for comprehensive recovery coverage.
Featured In Clinical Protocols
Gut Repair & Microbiome Restoration
Repair intestinal permeability (leaky gut), eliminate systemic inflammation, and restore microbiome balance using localized gastric regenerative peptides.
Advanced Injury Healing
Accelerate the physiological regeneration of severely damaged tendons, ligaments, and muscle fibers by deploying angiogenic and cell-migration peptides.
Post-Surgical Accelerated Healing
Dramatically reduce post-operative recovery times, minimize scar tissue formation, and rapidly heal physical incisions and internal trauma.
What to Expect
Weeks 1-2
- Reduced inflammation
- Less pain at injury site
- Improved gut comfort
- Continue protocol
- Maintain consistent timing
Weeks 3-4
- Noticeable improvement in injury healing
- Increased mobility
- Significant gut symptom relief
- Assess if dose adjustment needed
- Continue if seeing progress
Weeks 5-6+
- Substantial or complete healing
- Return to normal activity
- Lasting improvements
- Consider stopping if healed
- Take 2-4 week break
Dosing Quick Reference
Frequently Asked Questions
What is the standard BPC-157 dose?▼
How long should I run a BPC-157 cycle?▼
Should I inject BPC-157 near the injury site?▼
Can I stack BPC-157 with TB-500?▼
References
- Sikiric et al. “"BPC 157 and its role in healing".” Journal of Physiology-Paris (2018). PMID: 29898669
- Seiwerth et al. “"Gastric pentadecapeptide BPC 157 and wound healing".” Expert Opin Investig Drugs (2014). PMID: 24799263
- Chang et al. “"Effect of BPC 157 on tendon healing".” J Appl Physiol (2011). PMID: 21030672
📚 Related Articles
Get BPC-157 from our recommended source — independently tested, COA-verified, USP <85> endotoxin compliant. Use code 4SS6SFTUGB at checkout.
Affiliate link · Full review